| Drugs by Condition |  |
Non-Hodgkin's Lymphoma Medications
Definition of Non-Hodgkin's Lymphoma: Non-Hodgkin's lymphomas are cancers of lymphoid tissue (lymph nodes, spleen, and other organs of the immune system).
Drugs (by generic name) associated with Non-Hodgkin's Lymphoma
The following drugs and medications are in some way related to, or used in the treatment of Non-Hodgkin's Lymphoma. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See also...
Non-Hodgkin's Lymphoma Medications in the Pipeline
- June 5, 2007 - Biovest to File for Accelerated Conditional Approval of BiovaxID
- February 22, 2006 - Biovest International Submits Amendment Request to FDA for Use of Molecular Remission Data in the Ongoing Pivotal Phase 3 Study to Support Accelerated, Conditional Approval of BiovaxID, a Personalized Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma
- January 19, 2005 - FDA Issues Not Approvable Letter for Marqibo
- December 1, 2004 - INEX and ENZON Announce ODAC Does Not Support Accelerated Approval for Cancer Drug Marqibo
- September 27, 2004 - INEX and Enzon Announce Marqibo to be Reviewed by FDA's Oncologic Drugs Advisory Committee
- September 6, 2009 - FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA
- August 26, 2009 - FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone
- June 24, 2009 - Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
- April 14, 2009 - Cell Therapeutics Initiating Rolling NDA Submission For Pixantrone
Latest Non-Hodgkin's Lymphoma Blog Post
Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd
SEATTLE, June 22 /PRNewswire-FirstCall/ -- Updated follow-up phase III EXTEND (PIX 301) clinical trial data enhances previously reported superior response rates for pixantrone over comparator including in high risk patient subgroups
Additional Clinical...
View all Non-Hodgkin's Lymphoma blog posts.
Non-Hodgkin's Lymphoma Support Group Questions
Ask a Question about Non-Hodgkin's Lymphoma:
Learn more about Non-Hodgkin's Lymphoma
Medical encyclopedia results for:
